*Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise
Castellana M, Cignarelli A, Brescia F, Perrini S, Natalicchio A, Laviola L, et al
5.5 Appetite Disorders and Binge Eating By modulating central satiety pathways, semaglutide may help control compulsive eating behaviors
All of these options should also only be used as part of a medical weight loss treatment that involves maintaining a calorie deficient diet and regular exercise in order to provide successful weight loss results
Regain is common after discontinuation
But the signals are notable